Transport interactions of different organic cations during their excretion by the intact rat kidney. Organic cations, in addition to being filtrated, are secreted or reabsorbed in the proximal renal tubule whereby they have to pass the contraluminal and the luminal cell membrane. Interactions with the transport of other organic cations can occur at either cell side, leading to inhibition or stimulation of net secretion or net reabsorption. A qualitative evaluation of such processes is possible by using the in vivo bolus injection of an organic cation as test substance. Measuring its urinaly excretion profile in relation to that of inulin, under control conditions and after application of interfering organic cations, in combination with simultaneous registration of its tissue concentration, allows the demonstration of interaction and also the tentative identification of the cell side at which interference has taken place. As test substance the fluorescent organic cation 4-(4-dimethylaminostyryl)-N-methylpyridinium (4-Di-1-ASP; denotes permanent positively-charged organic cations was used, having a protein binding of 47% under the given experimental conditions. As interfering organic cations amiloride, benzylamiloride, choline, cimetidine, and 2-methyl-4-(heptafluorobutoxy-N-methylpyridinium were injected. It was found that: (1) 4-Di-1-ASP is filtered and net reabsorbed under control conditions (fractional excretion 0.54 0.1). All net secreted interfering substances, except bidirectional transported choline, injected simultaneously with 4-Di-1-ASP, showed an interference with renal excretion of net reabsorbed 4-Di-1-ASP, by (2) instantaneously increasing its reabsorption, resulting in a 28 to 33% decrease in urinary excretion, and (3) augmenting its tissue concentration by 19 to 58%. (4) A prolonged effect of the interfering substrates could be observed after a third injection of 4-Di-1-ASP (without inhibitor) showing an increased tissue concentration of 4-Di-1-ASP of 36 to 46%. The complex interfering pattern of the applied organic cations can be explained by a trans-stimulation of 4-Di-1-ASP net reabsorption at the luminal cell side, leading to an increased intracellular content of 4-Di-1-
substance, its excretion profile relative to that of inulin, under control conditions and after coinjection of interfering substances was measured. Simultaneous registration of the concentration of the test substance in the superficial tissue of the kidney, for the proximal tubular cells, which make up 70% of kidney surface [4] , allows the identification at which cell side interference has taken place. As test substances we used fluorescent dyes, sulfofluorescein (SF) in a previous [3] and 4-(4-dimethylaminostyryl)-Nmethylpyridinum (4-Di-1-ASP) in this study, which are substrates for several organic anion and organic cation transport systems. For being a suitable test substance, the fluorescent dye had to yield a good tissue fluorescence signal, and to be sufficiently excreted within the urine. To fulfill these requirements, the respective dye has to be transported at a high rate, which is commonly achieved by a reasonable affinity for the transport system.
For organic cation transport, we were able to identify as test substance the flourescent organic cation 4-(4-dimethylaminostyryl)-N-methylpyridinum (4-Di-1-ASP). Examining its excretion by the rat kidney, we found that 4-Di-1-ASP is net reabsorbed, and that several interfering organic cations, which are net secreted, are acutely enhancing its reabsorption, thereby leading to an increase in tissue concentration of 4-Di-1-ASP. Methods Chemicals and drugs 4-(4-Dimethylaminostyryl)-N-methylpyridinium (4-Di-1-ASP) and 2-(6-amino-3-imino-3H-xanthen-9-yl) benzoic acid methyl ester (rhodamine 123) were obtained from Molecular Probes (Eugene, OR, USA). Amiloride and choline were purchased from Merck (Darmstadt, Germany), benzylamiloride from Research Biochemicals International (Natick, MA, USA), and cimetidine from Sigma (Deisenhofen, Germany). 2-Methyl-4-(heptafluorobutoxy)-N-methylpyridinium was a gift from Dr. Lang (Hoechst AG, Frankfurt, Germany). [14C]Inulin was obtained from Du Pont (Dreieich, Germany). Animal preparation Experiments were performed on male Wistar rats (Winkelmann, Kirchborchen, Germany) 200 to 230 g of body weight, which were fed on Altromin standard diet and tap water. The animals were anesthetized by thiopental-sodium injection (Trapanal®; Byk Gulden, Konstanz, Germany), 120 to 150 mg/kg body weight, i.p. and placed on a heated operating table with a thermostat control set at 37°C. For injection of the test and interfering substances via a polyethylene catheter, the left jugular vein was cannulated. A small abdominal incision with placing another polyethylene catheter into the urinary bladder was made for collection of urine samples. Access to the left kidney was achieved by incision of the flank. After separation from the surrounding fascia the kidney was immobilized in a small plastic cup on cotton wool. Renal artery, vein and the ureter were left intact and in situ.
Measurement of tissue fluorescence
The device for continuous monitoring tissue content of the fluorescent cations was developed in our laboratory [5] . Briefly, it consists of an illuminating unit, a detector, and recording equipment. For generating light with a wavelength close to the excitation values of the fluorescent organic cations 4-(4-dimethylaminostyryl)-N-methylpyridinium (4-Di-1-ASP) and Rhodamine 123 (Rho 123), a halogen lamp (GBD 6433; Philipps, Kassel, Germany) together with several optical filters were used: a heat absorption filter (Spindler, Gottingen, Germany), a filter with variable angle (DT blue, Balzers, Liechtenstein), a dichroic filter magenta (DT magenta, Balzers, Liechtenstein), and a condenser (Spindler) for focusing to the light guide (type DB-3000, Deutsche Nichimen, Düsseldorf, Germany). The resulting light was guided through fiber optics to the surface of the kidney. To detect the emission from the superficial tissue of the kidney, a silicon photodiode (S 1133; Hamamatsu, Herrsching, Germany) was connected with two further filters: a band pass filter (DT green, Balzers, Liechtenstein) and a BG18 filter (Deutsche Nichimen).
The detection signal was amplified, and plotted on a chart recorder (Abimed, Langenfeld, Germany). During the experiments, the fluorescence equipment was positioned close to the surface of the kidney, with the light guide fixed in a suitable angle to the detection unit, allowing a continuous registration of changes in superficial kidney tissue fluorescence.
Determination of the apparent K, values for the used substances To test whether test and interfering substances were substrates for the contraluminal transport system for NMeN [1] , the luminal Ht'organic cation exchanger or the luminal transport system for choline [2] , stop-flow peritubular capillary perfusion experiments and luminal perfusion experiments were performed. The methods of measuring contraluminal and luminal influx of labeled substances into proximal tubular cells and the mode of evaluating transport parameters have been described previously [1, 2] The fluorescence measurements of 4-Di-1-ASP and Rho 123 in urine were carried out on a spectrofluorophotometer (Shimadzu RF-510; Gamma Analysentechnik, Bremerhaven, Germany) with excitation/emission wavelengths being 470 nm/605 nm and 495 nm/523 nm, respectively. A total of 0.1 ml of the original urine sample was diluted with 0.1 ml of 0.1 N NaOH solution and 2.9 ml of bidistilled water. Fluorescence intensities were cali- to five minutes after the injection of either 0.125 ml 4.9 mM 4-Di-1-ASP or Rho 123 (0.61 jsmol) into the jugular vein, the blood of the animals was drawn from the right ventricle, and the plasma was then separated by centrifugation. To yield the unbound fraction, the plasma was centrifuged with ultracentrifugation units (Centricon-Tm30; Amicon, Witten, Germany). The concentrations of the fluorescent organic cations in plasma and ultrafiltrate were determined as described above. Plasma protein binding (P) was calculated according to the equation: P = (Cgotaice)Ictotai with c,1 being the total dye concentration in plasma, and being the dye concentration in the ultrafiltrate.
Calculation of the fractional excretion
The calculation of the ratio of 4-Di-1-ASP excretion to inulin excretion was made by using the 25-minute excretion rates of 4-Di-1-ASP and inulin under control conditions and after injection of interfering substances. For evaluating the fractional excretion, that is, the ratio excreted amount/filtered amount of 4-Di-1-ASP and Rho 123, the fluorescent organic cation/inulin excretion ratio had to be multiplied by cfO,//cfr of the respective substance.
Microscopical investigation of renal tissue slices
Renal tissue slices were investigated by application of fluorescence microscopy to obtain further information about the intra- 
Results

Apparent K values of test and inhibitory substrates
The K, data show that for 4-Di-1-ASP and Rho 123, which were net resorbed, both luminal K, values were by a factor of 3 to 20 lower than the respective contraluminal K, values. On the other hand, substrates which, were net secreted, that is, cimetidine, amiloride, benzylamiloride and 2-methyl-4-(heptafluorobutoxy)-N-methylpyridinium had contraluminal K, values which were in the same range (by a factor of 2) or lower than the luminal K, values. Cho!ine, which, was at low concentrations net reabsorbed and at high concentrations net secreted had a contraluminal K, value which was 8 times higher than that for the luminal choline transporter but 15 times lower than that for the lumina! H/organic cation exchanger. Thus, the K, values indicated which direction net transport proceeds.
Excretion rates of the fluorescent test substrates within the utine and protein binding Five five-minute urine samples after injection containing the most substance were used to determine the excretion rate of the fluorescent dyes and ['4Cjinulin ( respectively). When 4-Di-1-ASP was injected without using an interfering substance, after the second injection no significant change in urinary excretion of 4-Di-1-ASP could be noted.
However, for the third injection of 4-Di-1-ASP (without inhibitor) an increase in urinary excretion compared to the first injection could be observed; this value is important as time control for judging the urinary excretion of the third injection of 4-Di-1-ASP (without inhibitor) after the second injection of 4-Di-1-ASPcI with inhibitor. In these cases the increase of 4-Di-I -ASP excretion was always lower (6 ± 9% to 20 ± 18%) than the time control (27 ± 22%, Table 2 ). The tissue concentrations of 4-Di-1-ASP show a significant increase as a prolonged effect (third 4-Di-1-ASP' injection) of the four organic cations cimetidine (46 ± 19%, P < 0.0001), amiloride (40 ± 32%, P < 0.01), benzylamiloride (38 ± 13%, P < 0.001), and 2-methyl-4-(heptafluorobutoxy)-N-methylpyridinium (36 ± 24%, P < 0.05), while no increase was seen in time control experiments or with cho1ine. Under the different maneuvers ['4C]inulin excretion did not change significantly, so that the fractional excretion rates of Di-1-ASP showed comparable changes as documented in Table   2 and depicted in Figure 3 A and C. Figure 3 B and D (Table 3) show a synopsis of the tissue concentration of our test substance under the influence of the different organic cations tested. 123] however, whereby the cytoplasmic fluorescence was weaker, revealed a prominent mitochondrial staining (Fig. 4 C, D) .
Discussion
The aims of the present study were: (1) to find a fluorescent organic cation, the net transport of which, that is, the net secretion or net reabsorption, by the kidney in situ can be clearly evaluated and Can be ascribed to identified transport processes of the proximal tubule; (2) to monitor the intracellular concentration of the fluorescent organic cation continuously by a noninvasive method; and (3) to reveal whether other organic cations change the net transport and tissue concentration of the fluorescent test substance.
Use of fluorescent dyes
For our purpose we applied a similar technique as in a previous study with organic anions [3] , where fluorescein and sulfofluorescein (SF, also known as "visible PAH" [71) were used. These fluorescent dyes were injected together with labeled inulin into the jugular vein of rats under osmotic diuresis and the urinary excretion as well as the fluorescence of the tissue at the surface of the kidney were measured.
Looking for florescent organic cations, we had to consider that cationic buffers can be sequestered in the acidic compartments (endosomes, lysosomes) by nonionic diffusion/ionic trapping [8, 9] . Additionally, cationic fluorescent substances are to a certain degree bound to cellular constituents and are apparently distributed in some cellular organdIes, for example mitochondria, according to the electrical potential difference [10] . Recent investigations, however, seem to demonstrate that also organic anions as fluorescence undergo some intracellular compartmentalization and binding to intracellular organelles [11] [12] [13] .
From the two fluorescent organic cations which we tested, that is, Rho 123 and 4-Di-1-ASP, it can be anticipated that only Rho 123 can accumulate in acidic intracellular compartments by nonionic diffusion/ionic trapping, but not the permanent cationic substance 4-Di-1-ASP. On the other hand, however, both substrates could be accumulated by the same mechanism, if the acidic intracellular organdies possess H 7organic cation exchangers. A recent study with endosomal vesicles indeed showed an ATP driven, ipH-dependent endosomal uptake of the organic cation tetraethyIammonium [14] .
From the beginning we took these characteristics of the fluorescent organic cations into account and concentrated on whether the tested substrates gave a good tissue signal which is quickly reversible. We selected two cationic dyes: rhodamine 123 (Rho 123) with two protonable groups, and chemically related to the fluoresceins for which our tissue fluorescence detection unit was adjusted [6] , and 4-(4-dimethylaminostyryl)-N-methylpyridinium (4-Di-1 -ASP), a quaternary ammonium compound which possesses a permanent positive charge, and in addition one protonable group (Table 1) . Both substances, because of their fluorescence, were originally introduced for vital staining of mitochondria [10, 15] . Rho 123 is also a substrate for the P-glycoprotein and has been used to identify multidrug resistant cells [16, 17] , which demonstrates functions other than solely mitochoridrial staining. 4-Di-1-ASP on the other hand, is a nontoxic vital fluorescent dye belonging to the class of styrylpyridinium dyes, which are used to stain living nerve terminals and glomeruli of the olfactory bulb [18, 19] . In a systematic investigation of the styrylpyridinium dyes, Irion et a! [20] demonstrated that 4-Di-1-ASP is the least lipophilic dye of the different derivatives tested, with an n-octanol water partition coefficient (P01w) of about 0.14. This relatively low hydrophobicity of 4-Di-1-ASP may be one reason why the selectivity for mitochondria might be not that high. Also Magrassi, Purves and Lichtman [18] do not attribute the uniformity and intensity of staining of nerve terminals with the ethyl derivative solely to mitochondrial staining, which is in accordance to our observations. The performed kidney tissue slice experiments (Fig. 4) showed a diffuse intense cytoplasmic staining at injection concentrations of the two test substances (4-Di-1-ASP and Rho 123) equivalent to these used in the inhibitory experiments. Only at much lower injection concentrations could a rapid mitochondrial staining be demonstrated. The measured fluorescence at the kidney surface can therefore be attributed to the presence of the respective fluorescent dye in the cytoplasm whereby the binding to other cell constituents, which is covered by the intense cytoplasmic staining, could not have contributed essentially to the measured tissue signal.
The organic cations investigated exhibited different affinities for the three transport systems (Table 1) . Rho 123 has a seventeenfold higher affinity for the luminal H47organic cation exchanger and a sixfold higher affinity for the luminal choline transporter than for the contraluminal organic cation transporter, while the affinity of 4-Di-1-ASP for the luminal H/organic cation exchanger is threefold and for the luminal choline transporter The phenomenon of interference of organic cations during their renal excretion has been subject of several recent investigations [21] [22] [23] [24] [25] [26] [27] [28] . Some studies have shown that interferences exist even between the transport of organic anions and organic cations [29] [30] [31] . This can occur with so-called hi-or polysubstrates-, that is, organic cations serving as substrates for the organic cation transport systems as well as the transport system(s) for organic anions or other transport systems [32] [33] [34] . As already shown for the renal transport of organic anions [3] , we were now able to demonstrate interactions of different organic cations during their transport by the kidney in situ.
The organic cations amiloride and cimetidine, which are net secreted by the kidney [35] , in BBMV preparations exhibit the characteristics of Hi/organic cation exchange with trans-stimulation or cis-inhibition by other organic cations and trans-stimulation by a H gradient [36] [37] [38] . Because of its similarity to amiloride regarding the apparent K1 values to the luminal and contraluminal transport systems for organic cations it can be anticipated that this is the case for benzylamiloride as well. Choline, on the other hand, underlies a bidirectional transport depending on its plasma concentration [39] , As could be demonstrated recently, a separate transport system for choline is located on the luminal cell side of the proximal tubule, driven by the electrical potential difference and not operating in exchange for H ions [2, 40, 41] . Although the inhibitory substrates all possess affinities for this transport system (Table 1) , several observations point in the direction of the H!organic cation exchanger being the more affected by the observed interaction phenomena. The affinities of each inhibitory substrate for both luminal transport systems are within the same range. Only cimetidine has a much weaker affinity (30-fold) for the luminal choline transporter. This difference permits making a distinction regarding the interaction with the luminal transport systems. Whereas it can be anticipated that both luminal transporters manage the reabsorption of 4-Di-1-ASP, the pronounced effect of cimetidine on overall reabsorption of 4-Di-1-ASP (Tables 2  and 3 , Fig. 3 ) speaks in favor of a higher proportion or capacitiy of the luminal H'1organic cation exchanger for mediating this effect. As demonstrated (Tables 2 and 3, Fig. 3 ), choline itself did not exert a significant effect on the transport of 4-Di-1-ASP.
We can therefore draw the conclusion, that, while injected simultaneously with test substance, the net secreted interacting organic cations have trans-stimulated the reabsorption of 4-Di-1-ASP at the site of the luminal H/organic cation exchanger with an accumulation of test substance in proximal tubular cells as a consequence. The least pronounced effect of 2-methyl-4-(heptafluorobutoxy)-N-methyIpyridinium (Tables 2 and 3 , Fig. 3 ) with the lowest affinity for the luminal H/organic cation exchanger (Table 1) supports this interpretation. A carryover effect of 4-Di-1-ASP handling was seen after the third control 4-Di-1-ASP injection in its urinary excretion but not in the tissue content (Tables 2 and 3, Fig. 3 ).
In general, the relatively high affinity of the test substance (4-Di-1-ASP) to the respective transporter limits the use of inhibitory organic cations, which either must have a higher affinity, or be applied at a much higher concentration at the transport site to displace the test substance, which can lead to unwanted systemic side effects. The aim of reaching a high inhibitor concentration at the transport site, however, is limited because of several reasons: first, the high protein binding of the used substances, second, their low water solubility, and third the small injection volume which did not permit the application of larger amounts of inhibitory substrates. Despite these limitations, all inhibitory organic cations used in this study showed a satisfactory interaction with the reabsorptive transport of 4-Di-1-ASP without causing severe adverse reactions.
Possible toxic effects by drug interactions
Toxic drug effects, which usually involve proximal tubular cells, depend on the degree of drug accumulation within these cells. [8, 9, 14] . For the future, attention should be paid to such possibilities. In addition, it should be evaluated how simple drug accumulation within the acidic endocytotic-lysosomal compartment might change the physiological function of these organelles, such as the breakdown of pinocytosed proteins [42] , and/or membrane targeting/recycling [43] .
Conclusions
Altogether, the method used in this study provides a useful tool to investigate overall transport of organic cations and their interactions in the kidney in vivo. We have identified two fluorescent organic cations, which, besides their excretion within the urine, can be monitored continuously in superficial tissue of the kidney. For continuous measurement of the cortical tissue concentrations, besides tissue fluorescence techniques, NMR spectroscopy has also been applied successfully [44] . By combining the two parameters, urinary excretion and tissue content, it is possible to determine the site of interaction at the luminal or contraluminal cell side of the proximal tubule. The performed experiments show the behavior of a fluorescent test dye which is net rcabsorbed and the interference with net secreted organic cations, among them widely used drugs, resulting in an increased intracellular concentration. From the opposite directions of net transport one would expect such an effect (trans-stimulation). This can be considered as an example, that also other organic cationic xenobiotics possessing affinity to the proximal organic cation transporters might reach higher intracellular concentration by substrate (drug) interaction, and finally might exert toxic effects to proximal tubular cells. For the future, it is desirable to study interaction phenomena with a eationic fluorescent test substance, net secreted by the kidney. In this regard, '9F NMR experiments with fluor-containing organic cations might be rewarding.
